FDA-labeled warnings include: Risk of thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Pancreatitis (report severe abdominal pain, with or without vomiting) Gallbladder disease (including gallstones and cholecystitis) Acute kidney injury secondary to dehydration from gastrointestinal symptoms Hypoglycemia when used with insulin or insulin secretagogues (dose adjustments may be needed) Diabetic retinopathy complications in patients with type 2 diabetes and pre-existing retinopathy Suicidal behavior and ideation (monitor for depression or suicidal thoughts) Intestinal obstruction/ileus (particularly with severe constipation) These medications are contraindicated during pregnancy and should be discontinued at least two months before a planned pregnancy

Patients who show low access to non-food sources of reinforcementsuch as meaningful activities or social connectednessoften benefit from interventions that strengthen alternative reinforcers
Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors
Thanks for sharing Lauren!
24/7 Profesionales de la salud disponibles siempre, con cobertura nacional
Lin SK, Tsai SM, Huang JC, Lee SC, Wu SH, Wu SH, et al